Results of the SARAH trial presented today demonstrate that SIRT resulted in median overall survival (OS) of 8.0 months compared to 9.9 months with sorafenib (p=0.179), in patients with locally advanced and inoperable hepatocellular carcinoma (HCC). The...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pnycej
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1tk1BEi via IFTTT
-
An in-depth look at what makes Rolex the industry leader and icon that they are, as we bring you inside the Rolex manufacturing facilities. ...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2p6KhjG via IFTTT
-
PSA! Has a TON of Scholarship Opportunities Right Now. SPOILER: college is crazy-expensive. Sorry. Did we spoil it? There are... from #Ale...
-
TAPinto.net Buddy Check9: Head, neck and throat cancers 9NEWS.com There are more than 70,000 Americans are diagnosed with head and n...
-
Purpose. To assess the long-term clinical outcomes of conventional laser in situ keratomileusis (LASIK) for moderate to high myopia. Methods...
-
Essay tungkol sa wika 2016 mary louise pratt essay diglyceride synthesis essay, issuu architecture dissertation pdf short essay 400 words es...
-
Abstract Shiga toxin-producing Escherichia coli (STEC) may cause haemolytic uraemic syndrome (HUS). Age ≤5 years and presence of stx2a a...
-
Fun math practice! Improve your skills with free problems in 'Solve two-step equations' and thousands of other practice lessons. f...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου